We have analyzed the association of DUSP16 with patient survival in two cohorts of cancer patients, a small cohort of HNSCC patients and a cohort of 113 breast cancer patients, and found that high DUSP16 levels in tumors were associated with significantly lower patient survival. The gene discussed is DUSP16; the disease is breast carcinoma.